Nicholas Basta

Like the other war on drugs, there's no end in sight

Abbott's spinout of AbbVie offers lessons

New study magnifies the lost opportunity for industry eighteen-fold; the global gap is $564 billion

Premier, one of the leading group purchasing organizations (GPOs), is a vital linkage point between nearly 90,000 healthcare sites in the US, and the drug, device and hospital-supply vendors that serve them. Pharmaceutical Commerce sat down with Mike Alkire, chief operating officer of the company, to hear about what's driving GPO evolution today, and how it interacts with pharma manufacturers. Here's what he had to say:

Industry is not waiting for action in Washington

Serialization systems are going into operation around the world, but cross-industry collaboration awaits new legislation

While 78% of survey respondents will "demand clear proof of cost savings" to ensure formulary placement, 44% of them have "little or no confidence" in the economic arguments presented by pharmacos

Dendreon's Provenge prostate-cancer treatment ramps up with unique supply chain complexities

Agency wins a 'campaign of the year' award from its client, Abbott Labs, for medical display

The leading chain pharmacy steps up its role as healthcare provider and partner to pharma

Compiling and maintaining lists of healthcare provider contacts is a bigger and more important task than ever

Ten-year BLS projection sees a healthy industry ahead

Compiling and maintaining lists of healthcare provider contacts is a bigger and more important task than ever

FDA's draft documents on biosimilar regulation move the prospect one step closer

Pharmaceutical Commerce sat down with Chris Smith, president and COO; here's what he had to say.

While 'data mining' is the catchphrase of the moment for business analytics, some pharma companies are finding value in mining their channel data assets

The pioneering firms that installed serialization and track-and-trace systems are being joined by a fast follower crowd, but an industry-wide commitment is still in the future

New edition of 'The Role of Distributors,' plus a new report on specialty pharmaceutical distribution, highlight distributors’ roles in healthcare

Pharma companies are beginning to staff up internally—in part out of dissatisfaction with the capabilities of outside marketing agencies they employ

Rapidly rising healthcare-products trade is almost being matched by increased regulatory scrutiny

With Rx-360 already at critical mass and delivering results, the call is out for more participation

The 'Sunshine Act' provisions of the Affordable Care Act require records to be kept beginning Jan. 1

PCMA study estimates additional $32 billion in added healthcare costs through 2021; coupons 'lure consumers to switch from generics to expensive brands'

A combination of regulatory processes and business practices are worsening an already-bad drug shortage situation

Long used in clinical research, cloud computing is now entering commercial and business applications

New HDMA 2011-2012 HDMA Factbook finds gradual growth in IT-based collaborations